Search

Displaying results 4321 - 4330 of 10000 in total
  1. Drug

    Cholesterol sulfate

    go.drugbank.com/drugs/DB01990
    Investigational

    Component of human seminal plasma & spermatozoa.

    Synonyms: Cholest-5-en-3beta-ol sulfateCategories: Compounds used in a research, industrial, or household setting
  2. Drug

    Aluminium

    go.drugbank.com/drugs/DB01370
    ApprovedInvestigationalWithdrawn

    A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98.

  3. Drug

    Troxacitabine

    go.drugbank.com/drugs/DB04961
    Investigational

    Troxacitabine is a nucleoside analog with antineoplastic activity. There has been growing interest in its development for the treatment of patients with refractory lymphoproliferative conditions.

  4. Drug

    Oxidized cellulose

    go.drugbank.com/drugs/DB13570
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Peruvoside

    go.drugbank.com/drugs/DB13756
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Coumarin 120

    go.drugbank.com/drugs/DB08168
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    Abafungin

    go.drugbank.com/drugs/DB06395
    Experimental

  8. Drug

    Nirogacestat

    go.drugbank.com/drugs/DB12005
    ApprovedInvestigational

    Desmoid tumors are typically characterized by aberrant activation in Notch signaling. … It was previously granted breakthrough therapy, fast track, and orphan drug designations for the treatment of desmoid tumors, and the final approval was based on positive results obtained in the Phase

  9. Drug

    Framycetin

    go.drugbank.com/drugs/DB00452
    ApprovedInvestigational

    A component of neomycin that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. (From Merck Index, 11th ed)

    International brands: Leukase N
  10. Drug

    ARG098

    go.drugbank.com/drugs/DB06338
    Experimental

    ARG098 (anti-Fas IgM monoclonal antibody) was studied in a Phase I clinical trial in 2007 involving patients with rheumatoid arthritis.